Please assess the completion status of the following clinical trial:

Trial Title: Ketofol vs Propofol for Emergency Department Procedural Sedation and Analgesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 14 years or greater~* deemed to require emergency department procedural sedation by the attending physician~Exclusion Criteria:~* unable to give informed consent~* hemodynamic instability~* pregnancy~* known allergy to either study medication

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Propofol alone (Type: ACTIVE_COMPARATOR): Patients receiving propofol alone.
- Ketofol (Type: ACTIVE_COMPARATOR): 0.375 mg/kg each of ketamine and propofol (mixed in the same syringe) as an initial bolus and 0.188 mg/kg each of ketamine and propofol as necessary until reaching deep sedation (Ramsay score = 5 or greater).

Based on this trial design, predict the completion outcome and termination type (if applicable).